Featured news in The Life Sciences Report



Viveve Medical Inc. (VIVE:NASDAQ)
Viveve Announces Regulatory Approval for Viveve System in Mexico (10/17/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
Bayer to Sell Select Business Lines to Close Monsanto Buyout (10/16/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Glaxo's Shingles Vaccine Shingrix Gets Approval in Canada (10/16/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
The Zacks Analyst Blog Highlights: Bayer Aktiengesellschaft, Monsanto, Adaptimmune Therapeutics and Celgene (10/17/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Immune Design's Sarcoma Candidate to Enter Phase III in 2018 (10/17/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Notified By FDA That It Can Proceed With Phase 2B Investigational New Drug Clinical Trial For Osteoarthritis Of The Knee (10/17/2017)

view
 

MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Warns Of Fake Emails (10/17/2017)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Announces Third Quarter 2017 Financial Results (10/17/2017)

view
 


Inovio Pharmaceuticals Inc. (INO:NASDAQ)
Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inhibitor in Advanced Bladder Cancer (10/16/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
MiMedx Announces Release Date for 2017 Third Quarter Results (10/16/2017)

view
 


BrainStorm Cell Therapeutics Inc. (BCLI:NASDAQ)
BrainStorm Enrolls First Patients in Phase 3 Trial of NurOwn® in ALS (10/16/2017)

view